Data as of Dec 19
| -0.12 / -7.06%|
The 3 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 18.00 and a low estimate of 1.00. The median estimate represents a +216.46% increase from the last price of 1.58.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.